Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ·Healthcare·Biotechnology
$2.98
-2.46%
Mkt Cap $1.60B
Analyst Ratings
Buy
3
Hold
2
Sell
0
Price Target (8 analysts)
$5.50
Range $5.50 – $5.50
Implied Upside
+84.9%
Consensus $5.50 vs current $2.98
NASDAQ·Healthcare·Biotechnology
$2.98
-2.46%
Mkt Cap $1.60B
Buy
3
Hold
2
Sell
0
Price Target (8 analysts)
$5.50
Range $5.50 – $5.50
+84.9%
Consensus $5.50 vs current $2.98